We are live on ! Find out more
SMC

S. Muoio & Co Portfolio holdings

AUM $75.7M
1-Year Est. Return 42.51%
This Fund
S&P 500
This Quarter Est. Return
-3.72%
1 Year Est. Return
+42.51%
3 Year Est. Return
+327.42%
5 Year Est. Return
+691.71%
10 Year Est. Return
–
AUM
$77.4M
AUM Growth
-$33.8M
Cap. Flow
-$12.5M
Cap. Flow %
-16.11%
Top 10 Hldgs %
44.92%
Holding
88
New
17
Increased
10
Reduced
28
Closed
25

Top Buys

Rank Stock Value
1
S
Sprint Corporation
S
+$2.81M
2
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
+$2.28M
3
TIF
Tiffany & Co.
TIF
+$2.11M
4
FTSV
Forty Seven, Inc. Common Stock
FTSV
+$1.94M
5
TCBI icon
Texas Capital Bancshares
TCBI
+$1.8M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$3.41M
2
NIHD
NII Holdings, Inc. Common Stock
NIHD
+$3.25M
3
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$2.43M
4
MDCO
Medicines Co
MDCO
+$1.7M
5
AZO icon
AutoZone
AZO
+$1.41M

Sector Composition

Rank Sector Weight
1 Technology 16.28%
2 Consumer Discretionary 14.41%
3 Healthcare 14.23%
4 Communication Services 12.91%
5 Financials 7.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZAYO
76
DELISTED
Zayo Group Holdings, Inc.
ZAYO
– –
-70,000
Closed -$2.43M
DPLO
77
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-100,000
Closed -$400K
CBPX
78
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
– –
-25,000
Closed -$911K
ACHN
79
DELISTED
Achillion Pharmaceuticals
ACHN
– –
-139,907
Closed -$844K
TOO
80
DELISTED
Teekay Offshore Partners L.P.
TOO
– –
-373,217
Closed -$575K
ARQL
81
DELISTED
Arqule Inc
ARQL
– –
-50,000
Closed -$998K
BOLD
82
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-57,000
Closed -$3.41M
WAIR
83
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
– –
-104,736
Closed -$1.15M
MDCO
84
DELISTED
Medicines Co
MDCO
– –
-20,000
Closed -$1.7M
TRCB
85
DELISTED
Two River Bancorp
TRCB
– –
-30,000
Closed -$672K
ENFC
86
DELISTED
Entegra Financial Corp.
ENFC
– –
-39,407
Closed -$1.19M
SMTA
87
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
– –
-153,000
Closed -$117K
NIHD
88
DELISTED
NII Holdings, Inc. Common Stock
NIHD
– –
-1,500,200
Closed -$3.25M
1 2 3
4

Similar funds

FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
PIMH
Prudence Investment Management (HK) 12 Harcourt Road Central, Hong Kong $78.2M AUM 52.44% 1-Year Est. Return

S. Muoio & Co's Q1 2020 Portfolio in Review

As of Q1 2020, S. Muoio & Co held 88 positions worth $77.4M, down 30% from $111M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

S. Muoio & Co withdrew a net $12.5M in Q1 2020, closing 25 positions and reducing 28 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $3.41M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 9.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, S. Muoio & Co opened a new position in Sprint Corporation worth $3.45M.

  • S. Muoio & Co's largest Q1 2020 buy was Sprint Corporation: 400,000 shares worth $3.45M.
  • S. Muoio & Co added most to Tiffany & Co. in Q1 2020, an estimated $2.11M increase.
  • S. Muoio & Co's biggest Q1 2020 reduction was AutoZone, cutting an estimated $1.41M.
  • S. Muoio & Co fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $3.41M.
  • S. Muoio & Co's ten largest holdings make up 45% of its $77.4M portfolio in Q1 2020.
  • S. Muoio & Co opened 17 new positions and closed 25 in Q1 2020.
  • S. Muoio & Co's portfolio value fell 30% quarter-over-quarter to $77.4M.

Based on S. Muoio & Co's 13F filing for Q1 2020, filed 14 May 2020.